Delhi/NCR:

Mohali:

Dehradun:

Bathinda:

Mumbai:

Nagpur:

Lucknow:

To Book an Appointment

Call Us+91 926 888 0303

How Multiple Myeloma Affects Body: Early Signs & Risk Factors

By Dr. Pratibha Dhiman in Bone Marrow Transplant , Hematology Oncology

Nov 09 , 2017 | 1 min read

1

Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell found in the bone marrow. These cells normally help the body fight infections by producing antibodies. However, in plasma cell cancer, abnormal plasma cells multiply uncontrollably and interfere with normal blood cell production. Common symptoms of multiple myeloma may include bone pain, fatigue, frequent infections, and kidney problems. Although it is a serious condition, advances in multiple myeloma treatment, including targeted therapy and immunotherapy, have significantly improved patient outcomes and quality of life.

What is Multiple Myeloma?

Multiple myeloma is a cancer that affects plasma cells, which are an important part of the immune system. These cells are produced in the bone marrow, the soft tissue inside bones that generates blood cells.

Normal Role of Plasma Cells

Plasma cells normally:

  • Produce antibodies to fight infections
  • Support immune system function
  • Help the body recognise harmful pathogens

What Happens in Multiple Myeloma

In bone marrow cancer like multiple myeloma, abnormal plasma cells grow uncontrollably and crowd out healthy blood cells. These cancerous cells also produce abnormal proteins that can damage organs such as the kidneys and bones.

As the disease progresses, it can interfere with the body's ability to produce normal red blood cells, white blood cells, and platelets.

How Multiple Myeloma Affects the Body

Multiple myeloma affects several systems in the body because plasma cells play a central role in immune function and blood production.

Bone Marrow

Cancerous plasma cells accumulate in the bone marrow, reducing the production of healthy blood cells. This can lead to anaemia, fatigue, and an increased risk of infection.

Immune System

Because abnormal plasma cells produce ineffective antibodies, the immune system becomes weaker. Patients may experience frequent infections due to reduced immunity.

Bones

Multiple myeloma often damages bones by disrupting the balance between bone formation and breakdown. This can lead to:

  • Persistent bone pain
  • Bone weakness
  • Increased risk of fractures

pain and cancer are commonly associated in advanced cases.

Kidneys

Abnormal proteins produced by myeloma cells can accumulate in the kidneys, affecting their ability to filter waste from the blood.

Kidney damage is a common complication of multiple myeloma.

Blood Cell Production

The overgrowth of cancerous plasma cells reduces the production of healthy blood cells, leading to conditions such as:

  • Anemia
  • Increased risk of infections
  • Bleeding or bruising problems

Early Signs and Symptoms of Multiple Myeloma

The early signs of multiple myeloma can be subtle and may develop gradually. Some patients may not notice symptoms in the early stages. Common multiple myeloma symptoms include:

  • Persistent bone pain, especially in the back or ribs
  • Fatigue and weakness caused by anaemia
  • Frequent infections due to reduced immunity
  • Unexplained fractures or fragile bones
  • Numbness or tingling in limbs
  • Excessive thirst or kidney problems

In many cases, these symptoms may be mistaken for other conditions. This is why a proper medical evaluation is important if symptoms persist.

Causes and Risk Factors

The exact causes of multiple myeloma are not fully understood. However, several factors are known to increase the risk of developing this disease.

  • Age: Multiple myeloma is more common in older adults, particularly individuals over the age of 60.
  • Genetic Factors: Certain genetic variations may increase susceptibility to plasma cell disorders.
  • Exposure to Radiation or Chemicals: Long-term exposure to radiation or certain industrial chemicals may increase the risk of developing blood cancer types such as multiple myeloma.
  • Monoclonal Gammopathy (MGUS): People with Monoclonal Gammopathy of Undetermined Significance (MGUS) have a higher risk of developing multiple myeloma. MGUS is a condition in which abnormal proteins are present in the blood, but without cancer symptoms.

How Multiple Myeloma is Diagnosed

Diagnosing multiple myeloma involves a combination of medical history, physical examination, and specialised laboratory tests.

Blood Tests

Blood tests help detect abnormal proteins and measure levels of:

  • Calcium
  • Hemoglobin
  • Kidney function markers

These tests may reveal early indicators of multiple myeloma diagnosis.

Urine Tests

Urine analysis can detect abnormal proteins known as Bence-Jones proteins, which are commonly associated with multiple myeloma.

Bone Marrow Biopsy

A bone marrow biopsy is one of the most definitive tests. A small sample of bone marrow is examined to detect abnormal plasma cells.

Imaging Tests

Doctors may use imaging techniques to detect bone damage. Common tests include:

  • X-rays
  • MRI scans
  • CT scans

These tests help determine how far the disease has progressed.

Treatment Options for Multiple Myeloma

Although multiple myeloma may not always be completely curable, modern treatments can control the disease and significantly improve patient outcomes.

  • Chemotherapy: Chemotherapy for multiple myeloma uses medications to destroy rapidly growing cancer cells. It is often used as an initial treatment or before stem cell transplantation.
  • Targeted Therapy: Targeted therapy focuses on specific proteins or pathways that allow cancer cells to grow.
  • Immunotherapy: Immunotherapy for multiple myeloma helps the body's immune system recognise and destroy cancer cells.
  • Stem Cell Transplant: A stem cell transplant may be recommended for eligible patients.

Supportive Treatments for Bone Health

Because multiple myeloma affects bones, supportive treatments may include:

  • Bone-strengthening medications
  • Pain management therapies
  • Physical rehabilitation

These treatments help reduce fractures and improve mobility.

Living with Multiple Myeloma

Living with multiple myeloma requires long-term medical care and lifestyle adjustments to maintain overall health.

Lifestyle and Nutrition

Maintaining a balanced diet rich in nutrients helps support the immune system and improve energy levels. Healthy lifestyle habits include:

  • Eating a nutrient-rich diet
  • Staying physically active as tolerated
  • Maintaining a healthy body weight

Infection Prevention

Because the immune system may be weakened, patients should take extra precautions to avoid infections. This may include:

  • Regular hand hygiene
  • Staying up to date with vaccinations
  • Avoiding exposure to contagious illnesses

Emotional and Mental Health

A cancer diagnosis can affect emotional well-being. Psychological support, counselling, and support groups can help patients cope with the emotional challenges of living with cancer.

When to Consult a Specialist

Early medical consultation is important if symptoms suggestive of multiple myeloma appear. You should consult a healthcare professional if you experience:

  • Persistent or unexplained bone pain
  • Frequent infections
  • Unusual fatigue or weakness
  • Unexplained fractures
  • Kidney-related symptoms

 

Early diagnosis allows doctors to begin treatment sooner, improving long-term outcomes.

Conclusion

Multiple myeloma is a complex form of blood cancer that affects plasma cells in the bone marrow and can impact several systems in the body. Early symptoms such as bone pain, fatigue, and recurrent infections should not be ignored. Advances in multiple myeloma treatment, including targeted therapies, immunotherapy, and stem cell transplantation, have significantly improved patient outcomes. Early diagnosis and appropriate medical care are essential for effectively managing the disease. Anyone experiencing persistent symptoms should consult a healthcare professional for proper evaluation and personalised treatment guidance.

Frequently Asked Questions

Is multiple myeloma a hereditary cancer?

Multiple myeloma is not typically considered a hereditary cancer, but certain genetic factors may increase the risk. Having a close family member with plasma cell disorders may slightly raise the likelihood of developing the condition.

Can multiple myeloma be detected through routine blood tests?

Routine blood tests may sometimes detect abnormal protein levels or anaemia that suggest a possible plasma cell disorder. However, additional tests, such as a bone marrow biopsy and specialised protein studies, are required to confirm the diagnosis.

What is the difference between MGUS and multiple myeloma?

MGUS is a condition in which abnormal proteins are present in the blood but without signs of cancer or organ damage. Multiple myeloma occurs when abnormal plasma cells grow uncontrollably, leading to symptoms such as bone damage, anaemia, and kidney problems.

Can lifestyle changes improve outcomes in patients with multiple myeloma?

Healthy lifestyle habits such as balanced nutrition, moderate physical activity, and infection prevention can support overall health during treatment. While lifestyle changes cannot cure the disease, they may help improve quality of life and recovery.

How fast does multiple myeloma progress?

The progression of multiple myeloma varies widely between individuals. Some cases progress slowly over many years, while others may advance more rapidly and require immediate treatment.

Are there new therapies being researched for multiple myeloma?

Yes, ongoing research is exploring innovative treatments such as CAR-T cell therapy, next-generation immunotherapies, and personalised medicine approaches. These advancements continue to improve survival rates and treatment outcomes.